American Society of Clinical Oncology - ASCO

ASCO Annual Meeting (#ASCO27) — In-Depth Event Research & Buyer-Attendee Insights

Event Overview (Official Details)

• Event: ASCO Annual Meeting — #ASCO27
• Dates: June 4–8, 2027
• Venue: McCormick Place, Chicago, IL, USA & Online

Why this event matters (industry context)

The ASCO Annual Meeting is a flagship oncology conference centered on advancing cancer care through scientific research, clinical best practices, and cross-functional connection across the oncology ecosystem. It combines high-level medical science content with a large exhibition presence where technology, diagnostics, therapeutics, and services organizations meet key stakeholders who influence clinical adoption, research collaboration, guideline development, and treatment pathways.

1️⃣ Who attends (BUYERS / ATTENDEES)

This is not only a physician-attendee conference. While oncologists and related clinical professionals are a core audience, the buyer-side decision-makers typically appear across several oncology-related functions—often with strong roles in research selection, evidence review, provider adoption, payer/clinical policy influence, clinical program leadership, and technology evaluation.

Primary attendee and buyer-side groups we should expect:

• Oncology clinical leadership: medical oncologists, hematologists/oncology specialists, oncology program directors, and care pathway leaders.
• Research & academic stakeholders: clinical researchers, trial coordinators, translational researchers, research operations leadership, and affiliated academic teams.
• Practice & health-system decision-makers: cancer center administrators, oncology service line leaders, clinical operations leaders, and outcomes/performance leadership.
• Industry exhibitors (high-intent buyers): biopharma, medical device and diagnostics organizations, oncology software/analytics providers, and research/services partners.
• Policy, guidelines and education ecosystem: medical affairs leadership and evidence communication teams who connect scientific data to practice.
• Patient care support & advocacy-linked roles: stakeholder groups working around patient navigation, support services, and patient access programs (depending on exhibitor composition).

Buyer takeaway: the strongest buyer fit usually comes from “medical + evidence + adoption” roles: Medical Affairs, Clinical Operations, Research/Trials leadership, Oncology Program leadership, Technology Evaluation, Outcomes & Real-World Evidence teams, and large sponsor organizations’ portfolio program leadership.

2️⃣ Where the show is happening + attendee geographic origin

Location (official): McCormick Place, Chicago, IL, USA & Online.

Geographic origin (what we can reliably infer from official metrics): ASCO reports that attendee participation spans a broad international set of countries. The event is anchored in the U.S., but it draws representation from multiple regions because oncology research is global and oncology innovation is internationally distributed.

Practical targeting guidance:

• U.S. national focus: Chicago and broader North America serves as the primary in-person draw for U.S.-based clinical, research, and sponsor organizations.
• International expansion: global participation is meaningful; we should include buyers with international clinical trials presence, global medical affairs teams, and multinational product portfolios.
• Online extension: online participation increases the practical reach beyond the host city and even beyond event-day geography.

3️⃣ Audience reach (Local / National / Global)

Based on ASCO’s published participation indicators, this event is best described as: National (U.S.) with Global reach, amplified by the virtual/online component and multinational sponsor/exhibitor ecosystem.

Reach takeaway: We should treat the event as a global oncology marketplace meeting—where the in-person Chicago audience provides dense networking, and the online layer expands the discoverability of content and participation across regions.

4️⃣ Sample buyer company names (BUYERS ONLY) + Websites

Below are buyer-style targets that commonly align with ASCO’s oncology focus: biopharmaceutical sponsors, large oncology research and technology organizations, and oncology-relevant device/diagnostics ecosystems. We provide a “Best title to target” column to help our team segment lists by decision influence.

Important note: ASCO lists many categories of exhibitors and sponsors. The most accurate buyer list depends on what your product specifically supports (therapeutics, diagnostics, clinical trials workflow, patient support, oncology software, data analytics, devices, etc.). We will refine the “best buyers” after we review your client’s website (see Section 8).

Top 5 sample priorities we recommend starting with: Genentech, Johnson & Johnson (Janssen), Merck & Co., AbbVie, AstraZeneca. These represent high-likelihood buyer fit because oncology medical affairs and clinical strategy functions are deeply embedded in their organizations.

5️⃣ Job profiles, industries & event type

Best job profiles to target

• Oncology Medical Affairs leadership: Director/Head/VP, Medical Affairs (Oncology), Medical Strategy.
• Clinical development & program roles: Global Clinical Program Lead, Director of Clinical Development, Clinical Operations Director.
• Evidence & outcomes roles: Evidence Strategy, Real-World Evidence (RWE), Outcomes Research leadership.
• Translational & research roles: Translational Science lead, Clinical Research Leader, Research Program Management.
• Oncology practice leadership: Oncology Program Director, Cancer Center Administration, Clinical Service Line leaders.
• Technology & data enablement: Oncology Solutions Director, Clinical Informatics leadership, Analytics/evidence enablement managers.
• Scientific communications: Scientific Communications lead, Medical Content Strategy.

Industries & event type (mapped to event reality)

• Event type: Scientific conference, medical education meeting, oncology research exchange, clinical best-practice forum.
• Primary buyer industries: Pharmaceuticals, Biotechnology, Medical Devices, Diagnostics, Health Tech, Clinical Research Services, Healthcare delivery/cancer center operations.
• Secondary buyer industries: Medical publishing/communications, analytics/R&D enablement, clinical trial management support services.

6️⃣ Estimated attendance (expected total footfall)

ASCO indicates that the ASCO Annual Meeting includes:

• Total attendees: 44K+ (ASCO-published figure for recent meeting context)
• Countries represented: 166 (indicating broad international participation)
• Exhibitors: 7,400 (strong signal of buyer presence and industry engagement)

Footfall expectation note for our planning: the meeting footprint supports a dense mix of clinical professionals, researchers, and a very large exhibitor community. Buyer density is typically highest among sponsor organizations’ medical affairs/clinical operations teams and technology/solutions providers that rely on conference-driven outreach.

7️⃣ Key focus areas & buyer engagement

Core focus areas we expect to drive buyer engagement:

• Breakthrough oncology research: new clinical evidence, study results, and practice-changing findings.
• Clinical best practices: evidence-based treatment decision-making and care pathway improvements.
• Innovation & technology translation: how next-generation therapies and tools move from trials into clinical workflows.
• Cross-stakeholder connectivity: scientific dialogue across researchers, clinicians, industry medical affairs, and clinical operations teams.
• Education and continued learning: structured educational programming and content access via official meeting platforms/app.

Buyer engagement opportunities (what we should position):

• Evidence-driven outreach: target roles responsible for translating data into practice, guideline-aligned adoption, and clinical program decisions.
• Clinical program sourcing: engage teams shaping clinical development strategy, trial planning, or real-world evidence programs.
• Solution adoption: reach oncology center leaders and technology evaluators who influence workflow integration.

8️⃣ Client-product fit alignment + buyer list selection (requires your client website)

We can absolutely refine the “best buyers” based on your client’s actual offering, but we need one critical input: please share your client’s website URL so we can match their product category (therapeutics, diagnostics, devices, clinical software, patient support, clinical research services, etc.) to the most relevant buyer titles and organizations for ASCO Annual Meeting.

What we will do after you share the website:

• Confirm the product category and the target customer type (pharma, diagnostics, cancer centers, clinical trials orgs, research sites, etc.).
• Map the buyer role language on your client’s website to conference-relevant job profiles (Medical Affairs, Clinical Ops, Evidence/RWE, Oncology program leadership, etc.).
• Prioritize “high-likelihood buyer” accounts for ASCO—so we deliver a list aligned with the real monetizable buyer segment for your offer.

Interim best-fit recommendations (until we review your website): based on common ASCO buyer behavior, we recommend prioritizing the following buyer segments for attendee-list sourcing:

• Pharma/biotech oncology Medical Affairs decision-makers
• Oncology Clinical Development & Clinical Operations leaders
• Evidence, outcomes, and real-world evidence strategy teams
• Oncology center and service-line leaders
• Oncology diagnostics and clinical technology evidence-adoption stakeholders

If you share your client website, we will revise our “Top 5 priorities” and tighten the buyer scoring so we avoid mismatched categories.

9️⃣ Industry suggestions (using the provided industry list)

To align with the industry categories available in your workflow, we suggest the following industry filters for ASCO-focused targeting:

• Hospital & Health Care
• Hospitality (only when targeting travel/accommodation-linked corporate partners—usually secondary)
• Pharmaceuticals
• Medical Devices
• Medical Practice
• Biotechnology (if available in your system; otherwise use Pharmaceuticals + Hospital/Health Care)
• Research
• Information Technology & Services (for oncology software, clinical informatics, trial enablement platforms)
• Computer Software (for healthcare analytics, clinical workflow tools, evidence platforms)
• Market Research (for outcomes/insights and evidence ecosystem firms)
• Professional Training & Coaching (secondary, for oncology education and training solutions)

Practical filter stacking: We recommend pairing industries above with job-title keywords such as “Medical Affairs”, “Clinical Development”, “Oncology”, “Clinical Operations”, “Evidence”, “RWE”, “Real World Evidence”, and “Outcomes”.

How we would position ASCO in our attendee-list research (buyer-centric, not generic)

When we present ASCO for attendee/buyer list purposes, we frame it as: a high-density oncology evidence and clinical adoption marketplace. The highest buyer value typically comes from those responsible for turning research into clinical action—medical affairs leadership, clinical program operators, evidence/outcomes strategists, and oncology center leaders.

Action Needed from You (to finalize “best buyers” for your client)

1. Send your client website URL.
2. Tell us which buyer type you want most (choose one or rank them):
   (a) Pharma/biotech sponsors, (b) Cancer centers/providers, (c) Diagnostics/devices, (d) Clinical research services, (e) Health-tech/software.
3. Confirm the geographic scope you want (U.S.-only vs global, and in-person vs online mix if relevant).

Once we have your client’s website, we will return a refined buyer shortlist (with updated priorities and best title targeting) tailored specifically to your client’s needs for #ASCO27.